[ad_1]
As reported, in Austria, a certain dose of AstraZeneca was temporarily not vaccinated after a nurse died of blood clotting complications and her colleague was hospitalized with a pulmonary embolism after both were vaccinated.
Austria’s Federal Office of Health (BASG) said on Sunday there was no evidence of a causal link between vaccination and death and disease, but both cases are being thoroughly investigated and vaccination will be suspended as a precaution until the association is completely discarded. .with the remaining vaccines from the affected AstraZeneca shipment, MTI wrote.
The two nurses worked in the same practice in the city of Zwettl in Baja Astria. One of them, a 49-year-old woman, was hospitalized with severe bleeding disorders and died the next day. You received the AstraZeneca vaccine ten days before your death. His colleague of 35 years, who has been treated for pulmonary embolism, and has improved since then, was also previously vaccinated with AstraZeneca.
Based on the available clinical data, there is no association between the two cases and the administration of the AstraZeneca vaccine, as thrombotic events are not among the known or characteristic side effects of the vaccine. No such cases have been reported in foreign adverse reaction reports.
– said the Austrian Federal Health Office in a statement released on Sunday.
“For our own benefit and that of all concerned, we strongly support the investigation of the unfortunate case,” reacted vaccine manufacturer AstraZeneca, indicating that it is in contact with the Austrian authorities and fully supports the investigation.
“The European Medicines Agency (EMA) and the World Health Organization (WHO) have licensed the vaccine based on clinical trials in 23,000 people worldwide. These evaluations demonstrate that the AstraZeneca vaccine is effective and safe ”, emphasized the company.
The British-Swedish pharmaceutical group AstraZeneca, together with the University of Oxford, has developed its vaccine against the coronavirus. In Germany, more than 360,000 people received the vaccine between the beginning of February and 26, and the side effects in all cases coincided with the safety profile established in clinical trials, recalls MTI.
[ad_2]
